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3C-like proteaseTo address the regulation and evolution of precursor protein cleavability in caliciviruses, we examined
constraints on diversity of upstream regions of calicivirus precursor cleavage sites. We performed alanine
scanning and supplementary mutagenesis of amino acids at P1, P2, P3, and P4 sites using four viruses
representing the four major genera of the family Caliciviridae. This study complements previous mutagenesis
studies and shows strong restrictions in mutations at the P1 and P4 sites for effective cleavage reactions. By
contrast, such restrictions were less frequently observed at the P2 and P3 sites. Shannon entropy analysis of
the reported sequences showed that the P2, P3, and P4 sites allow variations in amino acid size within a
calicivirus genus whereas the P1 sites do not. Notably, the human sapovirus precursor protein exceptionally
retains a basic rather than aromatic amino acid at the P4 site of the NS4/NS5 cleavage site in reported strains,
and a substitution from basic to aromatic amino acid signiﬁcantly enhanced cleavability at this site. Taken
together, these data suggest the existence of (i) structural constraints on the P1 site that restrict size changes
within each calicivirus genus, (ii) plastic substrate surfaces that accommodate size variation at the P2, P3,
and P4 sites and modulate their own cleavabilities, and (iii) biological constraints on the P4 site that
maintain the lower cleavability of the NS4/NS5 site in sapovirus.
© 2009 Elsevier Inc. All rights reserved.Introduction
Caliciviruses are non-enveloped RNA viruses whose virus parti-
cles contain a single-stranded, positive-sense, polyadenylated RNA
genome of about 7.3–8.3 kb with either two or three open reading
frames (ORFs). Caliciviruses are currently classiﬁed into four major
genera, Sapovirus, Norovirus, Lagovirus, and Vesivirus, on the basis of
genome structure and diversity (Green, 2007). Relatively well-
characterized representatives of these four genera are Sapporo virus
(SaV), Norwalk virus (NoV), Rabbit hemorrhagic disease virus (RHDV),
and Feline calicivirus (FCV), respectively.ational Institute of Infectious
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ll rights reserved.The calicivirus RNA genome encodes a cysteine protease, termed
a 3C-like protease, in ORF1 (Clarke and Lambden, 1997). The
protease is initially synthesized as a part of ORF1 and cleaves the
ORF1 polyprotein into multiple mature proteins (Clarke and
Lambden, 2000). In the case of Vesivirus, viral protease additionally
cleaves ORF2-encoded protein and generates the mature capsid
protein VP1 (Matsuura et al., 2000; Oehmig et al., 2003; Rinehart-
Kim et al., 1999; Sosnovtsev et al., 2002, 1998). The critical role of
Cys in the calicivirus protease motif GDCG in the cleavage activity
has been determined previously (Boniotti et al., 1994; Liu et al.,
1996; Oka et al., 2005; Sosnovtseva et al., 1999). This processing is
essential for generating infectious mature virus particles (Sosnovt-
sev et al., 2002, 1998).
The calicivirus protease cleaves peptide bonds downstream of the
glutamic acid (E) or glutamine (Q) in the precursor protein (Green,
2007). However, these amino acid residues are found frequently in
non-cleavage sites of viral precursor proteins, indicating that addi-
tional amino acids participate in recognition and cleavage by viral
proteases. Consistently, previous mutagenesis studies have suggested
that amino acids immediately upstream of the scissile bonds of the
substrates play important roles in determining substrate cleavage
speciﬁcity and efﬁciency (Belliot et al., 2003; Hardy et al., 2002; Robel
120 T. Oka et al. / Virology 394 (2009) 119–129et al., 2008; Schefﬂer et al., 2007, 1998; Wirblich et al., 1995). These
studies were exclusively done with a single virus strain at a time; in
addition, they focused on particular P positions of cleavage sites. No
studies have systemically analyzed the set of P1, P2, P3, and P4 posi-
tions of the cleavage site, numbered according to the method of
Schechter and Berger (1967). Furthermore, amutagenesis study at the
P2 and P4 positions is lacking in Vesivirus.
To extend previous ﬁndings and obtain new information on the
regulation and evolution of precursor protein cleavability in calici-
viruses, we examined here constraints on the diversity of the regions
upstream of calicivirus precursor cleavage sites. We conducted muta-
genesis of amino acids at the P1, P2, P3, and P4 sites of representative
cleavage sites of SaV, NoV, RHDV, and FCV precursors. A total of 34
mutants examined in this study have not been fully reported
previously; therefore, our results complement those of previous
mutagenesis studies. Furthermore, we also examined variations in
size and chemical properties of the amino acids at the P1, P2, P3, and
P4 positions within each calicivirus genus, using reported precursor
sequences and Shannon entropy scores (Motomura et al., 2008;
Naganawa et al., 2008; Shannon, 1997). Together with previous
mutagenesis studies, our study provides a basis to understand both
structural and biological constraints on the diversity of regions
upstream of the proteolytic cleavage sites of the calicivirus precursor
proteins.
Results
Site-directed mutagenesis of SaV P1, P2, P3, and P4 positions
The SaV strain Mc10, whose ORF1 polyprotein is 2278 aa in
length and whose six cleavage sites have been experimentally
determined (Oka et al., 2006), was used as the starting material for
the present mutagenesis (Fig. 1A). A panel of ORF1 mutants having
a single amino acid substitution at regions immediately upstream of
cleavage sites was constructed with pUC19/SaV Mc10 full-length
(see Materials and methods). A wild-type ORF1 (Prow) (Fig. 1B; lane
Prow, ﬁlled arrowheads) and an ORF1 mutant having a C1171A
mutation at the catalytic site of protease (Promut) (Fig. 1B; lane
Promut, a open arrowhead) were included in the study as positive
and negative controls for the ORF1 polyprotein processing, res-
pectively (Oka et al., 2005, 2006, 2007). Alanine substitution
mutants at the P1 position of the NS1/2, NS2/3, NS3/4, NS5/6-7,
and NS6-7/VP1 cleavage sites (Fig. 1B; E69A, Q325A, Q666A,
E1055A, and E1722A) and a double alanine mutant at the P2 and
P1 positions of the NS4/5 cleavage site (Fig. 1B; E939A, E940A)
were included in the study as controls to inhibit the individual
cleavage sites (Oka et al., 2006).
When Prow was expressed and incubated for 3 h, more than 10
products were detected, among which 9 products corresponded in
size to mature or relatively stable intermediate proteins, such as
NS1, NS2, NTPase (NS3), 3A (NS4), VPg (NS5), NS2-3, 3A-VPg
(NS4-5), 3A-VPg-ProPol (NS4-5-6-7), and VP1 (Fig. 1B; lane Prow,
ﬁlled arrowheads). As reported previously (Oka et al., 2005, 2006),
these products were not detected with the Promut translation
product; instead, a high-molecular-weight protein corresponding
to the full-length ORF1 was detected (Fig. 1B; lane Promut, a open
arrowhead). The results indicate that the nine products in the
Prow sample were the proteolytic products of the ORF1 precursor
protein. Precise origin of the approximately 70-kDa product is
difﬁcult to elucidate because this band is visible when ORF1
polyprotein containing either wild or mutant protease was
expressed (Fig. 1B; lanes Prow and Promut) (Oka et al., 2005).
Aberrant processing patterns of the SaV mutant ORF1s as com-
pared with those of the Prow ORF1 were frequently detected (Fig.
1B; F66A to E1722A, bold letters). For example, when an alanine
substitution was introduced at the P4 or P1 position of the NS1/2cleavage site, processing patterns were partially different from
those of Prow (Fig. 1B; F66A and E69A); the amounts of mature NS1
and NS2 products decreased, the NS2-3 intermediate disappeared,
and a novel band roughly corresponding to the size of the un-
processed NS1-2 intermediate appeared in the P4 and P1 site
mutants (Fig. 1B; F66A and E69A, asterisks). The novel band of the
F66A sample was somehow slightly larger than that of the E69A
sample. However, both products speciﬁcally reacted with the anti-A
antibody (Oka et al., 2005) by immunoprecipitation (data not
shown), indicating that they are related to the unprocessed NS1-2
intermediate products. Together, the results suggest severe atten-
uation of NS1/2 cleavability by P4 or P1 single-site mutation. By
contrast, no signiﬁcant differences were detected with the P3- and
P2-site mutants of the NS1/2 cleavage region as compared with
Prow (Fig. 1B; T67A and E68A). From these results, we concluded
that both the P4 and P1 residues are important for the processing at
the NS1/2 cleavage site while the P3 and P2 residues are not
necessarily critical to the substrate cleavability.
The crucial roles of the P4 site in the SaV ORF1 polyprotein
processing were further evaluated with other ﬁve cleavage sites,
NS2/3, NS3/4, NS4/5, NS5/6-7, and NS6-7/VP1, in the ORF1
polyprotein, because the amino acid residues at the P4 position of
individual cleavage sites are highly conserved among the SaV strains
(Oka et al., 2006). Similarly, effects of single mutations at the P1 site
with the four cleavage sites and double mutation at P2 and P1 with
the NS4/5 site were examined. Aberrant processing patterns were
detected in four mutants with an alanine substitution at the P4
position (Fig. 1B; F322A, F663A, Y1052A, and F1719A) and four
mutants with an alanine substitution at the P1 position (Fig. 1B;
Q325A, Q666A, E1055A, and E1722A). The aberrant cleavage patterns
of the ORF1 polyprotein in the P1 and the P4 mutants were very
similar when the same cleavage sites were compared. Newly
appeared (asterisks), decreased, or disappeared bands in the mutants
could be explained by decreased efﬁciencies of cleavages around the
mutation sites (Fig. 1B).
The P4 site in SaV is generally occupied by either an aromatic or
hydrophobic amino acid (Fig. 1A) (Oka et al., 2006). However, the
P4 site of the NS4/NS5 cleavage site exclusively has a basic amino
acid in all human SaV strains reported thus far. An alanine sub-
stitution at the P4 position of the NS4/NS5 cleavage site did not
cause signiﬁcant processing defects (Fig. 1B; R937A), but a sub-
stitution from arginine (R) to F resulted in a drastic increase in
amounts of mature NS4 and NS5 products (Fig. 1B; R937F). These
increases were accompanied by the disappearance of NS4-5 and
NS4-5-6-7 intermediate products, suggesting enhancement of the
cleavability of the NS4-5 boundary by the R-to-F mutation. In
contrast, a substitution from one aromatic to another aromatic
amino acid substitution (Y to F) at the P4 position of the NS5/6-7
cleavage site did not cause signiﬁcant processing defects or en-
hancement (Fig. 1B; Y1052F).
Together, our mutagenesis study has demonstrated that the
aromatic amino acids (F or Y) at the P4 position of the NS1/NS2,
NS2/NS3, NS3/NS4, NS5/NS6-7, and NS6-7/VP1 cleavage sites play
a key role in maintaining relatively high levels of substrate cleava-
bility and that R at the P4 position of NS4/NS5 plays a key role in
suppressing cleavability at this site.
Site-directed mutagenesis of NoV P1, P2, P3, and P4 positions
The NoV strain U201, whose ORF1 polyprotein is 1702 aa in length
(Katayama et al., 2006), was used as the starting material for the
mutagenesis. Cleavage sites of the U201 ORF1 polyprotein were
assigned on the basis of information on a processingmap of other NoV
strains (Belliot et al., 2003; Green, 2007) and sequence alignment
(Fig. 2A). A wild-type ORF1 (Prow) and an ORF1 mutant having a
C1150A mutation at the catalytic site of protease (Promut) were
Fig. 1. Effects of amino acid substitutions introduced into the cleavage sites of the SaV ORF1 polyprotein. (A) Schematic representation of proteolytic cleavage sites of SaV Mc10
ORF1 polyprotein, P4, P3, P2, P1, and P1′ amino acid residues for the cleavage sites, and processing intermediates (Oka et al., 2006). (B) SDS–PAGE of in vitro 35S-labeled
proteins derived from the wild-type sequence, ORF1-Prow, and ORF1-ProC1171A (ORF1-Promut forms) of the entire ORF1 region (aa 1–2278) and 16 mutants: ORF1-F66A,
−T67A, −E68A, −E69A, −F322A, −Q325A, −F663A, −Q666A, −R937A, −R937F, −E939A, E940A, −Y1052A, −Y1052F, −E1055A, −F1719A, and −E1722A. NS1 and NS5
were immunoprecipitated with region-speciﬁc antibodies, anti-A and anti-D (Oka et al., 2005), respectively. The protein bands speciﬁc to either the Prow or Promut forms of the
entire ORF1 regions are indicated by ﬁlled and open arrowheads, respectively. Asterisks indicate newly appearing products. The viral proteins are shown on the right, and size
markers are shown on the left. Thirteen mutants – ORF1-Promut, −F66A, −E69A, −F322A, −Q325A, −F663A, −Q666A, −R937F, −E939A, E940A, −Y1052A, −E1055A,
−F1719A, and −E1722A – in which the proteolytic processing was affected are indicated in boldface type.
121T. Oka et al. / Virology 394 (2009) 119–129included in the study as positive and negative controls for the ORF1
polyprotein processing, respectively.
When Prow was expressed and incubated for 3 h, several products
corresponding in size to the Nterm (NS1-2), NTPase (NS3), Pol (NS7),
and 3A-VPg-Pro-Pol (NS4-5-6-7) proteins were detected (Fig. 2B;
Prow, ﬁlled arrowheads), as in another study (Belliot et al., 2003).
Further incubation for up to 16 h resulted in the generation of
additional products corresponding to the 3A (NS4), Pro (NS6), 3A-VPg(NS4-5), and Pro-Pol (NS6-7) proteins (data not shown). In contrast,
when Promut was expressed and incubated for 3 h, generation of these
products was severely suppressed. Instead, a product corresponding
to the entire ORF1 polyprotein was predominantly detected (Fig. 2B;
Promut, open arrowhead). These results showed that two of the
cleavage sites, NS1-2/NS3 and NS3/NS4, were cleaved more efﬁ-
ciently than the others (Figs. 2A and B). Therefore, we examined the
role of the four amino acid residues upstream of these two sites in the
Fig. 2. Effects of amino acid substitutions introduced into the cleavage sites of the NoV ORF1 polyprotein. (A) Proteolytic cleavage map of the NoV U201 ORF1 polyprotein and
processing intermediates. The locations and designations of the proteins have already been identiﬁed (Belliot et al., 2003; Green, 2007). The P4, P3, P2, P1 and P1′ amino acid residues
for two cleavage sites analyzed in this study are indicated. (B) SDS–PAGE of in vitro 35S-labeled proteins derived from the wild-type sequence, ORF1-Prow, and ORF1-ProC1150A
(ORF1-Promut forms) of the entire ORF1 region (aa 1–1702) as well as eight mutants: ORF1-Y330A, −E331A,−M332A,−Q333A, −F696A,−E697A, −L698A, and−Q699A. The
protein bands speciﬁc to either the Prow or Promut forms of the entire ORF1 region are indicated by ﬁlled and open arrowheads, respectively. Asterisks indicate newly appearing
products. The viral proteins are shown on the right, and size markers are shown on the left. The mutants in which proteolytic processing was affected, ORF1-Promut, −Y330A,
−M332A, −Q333A, −F696A, −L698A, and −Q699A, are indicated in boldface type.
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alanine in turn.
Aberrant processing patterns of the NoV mutants ORF1 as com-
pared with those of the Prow ORF1 were frequently detected (Fig. 2B
Y330A to Q699A, bold letters). When an alanine substitution was
introduced at the P4, P2, or P1 position of the NS1-2/NS3 or the NS3/
NS4 cleavage site, processing patterns that were partially different
from those of Prow were detected; a novel band roughly corres-
ponding in size to unprocessed intermediate products appeared with
these mutants (Fig. 2B, asterisks). The appearance of these new
products could be explained by attenuation of cleavability at the
mutation sites. By contrast, no signiﬁcant differences were detected in
the P3 site mutants of the NS1-2/NS3 and NS3/NS4 cleavage regions
as compared with Prow (Fig. 2B; E331A and E697A).
Together, our mutagenesis study has demonstrated that the amino
acid residues at the P4, P2, and P1 positions of the NS1-2/NS3 andNS3/NS4 cleavage sites of NoV play key roles in determining efﬁcient
substrate cleavability.
Site-directed mutagenesis of RHDV P1, P2, P3, and P4 positions
The novel RHDV strain Hokkaido, with an ORF1 polyprotein 2344
aa in length (Fig. 3A), was used as the starting material for the
present mutagenesis. Cleavage sites of the Hokkaido ORF1 poly-
protein were assigned on the basis of information on the processing
map of another RHDV strain (Meyers et al., 2000; Wirblich et al.,
1995; Wirblich et al., 1996) and sequence alignment (Fig. 3A). The
wild-type ORF1 (Prow) and an ORF1 mutant having a C1212A
mutation at the catalytic site (Promut) were included for the study
as positive and negative controls for the ORF1 polyprotein proces-
sing, respectively. The NS3/NS4 site of the RHDV ORF1 polyprotein
(Fig. 3A) was selected in the present study.
Fig. 3. Effects of amino acid substitutions introduced into the cleavage sites of the RHDV ORF1 polyprotein. (A) Proteolytic cleavage map of the RHDV Hokkaido ORF1 polyprotein
and processing intermediates. The locations and designations of the proteins have been adopted (Martin Alonso et al., 1996; Meyers et al., 2000; Wirblich et al., 1996). The P4,
P3, P2, P1, and P1′ amino acid residues of the cleavage site in the ORF1 polyprotein analyzed in this study are indicated. (B) SDS–PAGE of in vitro 35S-labeled proteins derived
from the wild-type sequence, ORF1-Prow, and ORF1-Promut forms of the entire ORF1 region (aa 1–2344) as well as six mutants: ORF1-A715K,−A715W,−A715K,−S716A,−F717A,
and –E718A. The protein bands speciﬁc to either ORF1-Prow or ORF1-ProC1212A (ORF1-Promut forms) of the entire ORF1 region are indicated by ﬁlled and open arrowheads,
respectively. Asterisks indicate newly appearing products. The viral proteins are shown on the right, and size markers are shown on the left. Six mutants in which proteolytic
processing was affected – ORF1-Promut,−A715K,−A715W,−A715K,−F717A, and−E718A – are indicated in boldface type.
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responding in size to the NS1, NS2, NTPase (NS3), 3A (NS4), VPg
(NS5), Pro (NS6), Pol (NS7), 3A-VPg (NS4-5), Pro-Pol (NS6-7), VPg-
Pro-Pol (NS5-6-7), 3A-VPg-Pro-Pol (NS4-5-6-7), and VP1 proteins
were detected (Fig. 3B; Prow, ﬁlled arrowheads). In contrast, when
Promut was expressed and incubated for 3 h, the generation of these
products was severely suppressed, and instead a product
corresponding to the entire ORF1 polyprotein was predominantly
detected (Fig. 3B; Promut, open arrowheads).
Aberrant processing patterns of the RHDV mutants ORF1 as
compared with those of the Prow ORF1 were frequently detected
(Fig. 3B A715K to E718A, bold letters). An alanine substitution was
introduced at the P3, P2, or P1 position of the NS3/NS4 cleavagesite, and other substitution was introduced at the P4 position at
this site because the native aa for residue 715 at P4 position is A
(Fig. 3A). The processing patterns that were partially different from
those of Prow were detected: novel bands roughly corresponding
to the size of unprocessed intermediate products appeared with
these mutants (Fig. 3B, asterisks). The appearance of these new
products could be explained by the attenuation of cleavability at
the NS3/NS4 site.
By contrast, no signiﬁcant differences were detected between the
P3 site mutant and Prow (Fig. 3B; S716A). Together, our mutagenesis
study has demonstrated that the amino acid residues at P4, P2, and P1
of the NS3/NS4 cleavage site of RHDV play key roles in determining
substrate cleavability.
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Vesivirus is unique among the calicivirus genera in that the viral
protease in ORF1 cleaves not only the ORF1 polyprotein but also the
ORF2-encoded capsid (VP1) precursor protein to generate mature
VP1 (Sosnovtsev et al., 1998) (Fig. 4A). In the present study, we
examined the roles of the P1, P2, P3, and P4 amino acids in FCV VP1
precursor protein cleavability. The FCV strain F4, whose VP1 precur-
sor protein is 668 aa in length, was used as the starting material for
the mutagenesis. The cleavage site of the F4 VP1 precursor protein
was assigned on the basis of information on the processing map of
another FCV strain (Sosnovtsev et al., 1998) and sequence
alignment. A wild-type ORF2 (WT ORF2) was included in the
study as a positive control for the VP1 precursor protein processing.
When the WT ORF2 was expressed and incubated with the pro-
tease active or inactive ORF1 for 3 h, a single major product corre-Fig. 4. Effects of amino acid substitutions introduced into the cleavage site of the FCV
capsid precursor protein. (A) Cleavage map of the FCV F4 capsid (VP1) precursor
protein. The P4, P3, P2, P1, and P1′ amino acid residues at the cleavage site in the capsid
precursor protein have been adopted from Sosnovtsev et al. (1998). (B) SDS–PAGE of in
vitro 35S-labeled proteins derived from the wild-type sequence, ORF2-native, of the
entire ORF2-encoded protein (aa 1–668), and four mutants (ORF2-F121A, −R122A,
−L123A, and −E124A) that were incubated with non-radiolabeled FCV F4 ORF1
polyprotein as a source of protease in trans. ORF2 native was also incubated with non-
radiolabeled FCV F4 ORF1 polyprotein with protease mutant in trans. The viral proteins
are shown on the right, and size markers are shown on the left. The three mutants –
ORF2-F121A,−R122A, and −E124A – with active protease and the ORF2 native with
inactive protease showing affected proteolytic processing are indicated in boldface
type.sponding in size to mature VP1 or VP1 precursor protein was
detected (Fig. 4B; WT ORF2 with Prow, or Promut). However, when the
mutant ORF2 with a single alanine substitution at P4, P3, or P1 was
incubated with active protease, a major product with a larger mole-
cular size, corresponding in size to the VP1 precursor protein, was
detected (Fig. 4B; F121A, R122A, and E124A). The appearance of the
larger product was accompanied with a marked decrease in the
amounts of mature VP1 products in the P1, P3 and P4 site mutants. By
contrast, no signiﬁcant differences were detected in the P2 site
mutant as compared with the WT ORF2 (Fig. 4B; L123A).
Altogether, our mutagenesis study has demonstrated that the
amino acid residues at the P4, P3, and P1 positions of the VP1 pre-
cursor protein cleavage site play key roles in determining substrate
cleavability.
Variations in chemical properties and size of amino acids at the P1,
P2, P3, and P4 sites
Amino acid variations at P1, P2, P3, and P4 positions of precursor
cleavage sites were examined with reported sequences of SaV, NoV,
RHDV, and FCV strains. Sequences of calicivirus full-length ORF1 and
ORF2 were collected from a public database, and a total of 589
cleavage site sequences were used for the variation study. Shannon
entropy scores (Motomura et al., 2008; Naganawa et al., 2008;
Shannon, 1997) were calculated with amino acid sequences for each
virus group (n=114, 160, 231, and 84 sequences for SaV, NoV, RHDV,
and FCV strains, respectively) and used as the indicator of amino acid
variations at individual positions; a score of zero at a given position
indicates absolute conservation at the position, whereas a score of 4.4
indicates complete randomness.
As shown in Fig. 5A, the entropy scores generally ranged from 1.0
to 3.0 at the P1, P2, P3, and P4 positions of precursor polyprotein
cleavage sites of SaV, NoV, RHDV, and FCV, indicating that the four
amino acids immediately upstream of cleavage sites of calicivirus
polyproteins are relatively variable independent of viral genera. An
exception was the P1 position of FCV. When the entropy scores were
calculated on the basis of chemical properties of amino acids (Fig. 5B),
levels and distribution patterns of the scores were essentially similar
to those shown in Fig. 5A. The data indicate that the P1, P2, P3, and P4
sites generally accommodate amino acids with distinct chemical
properties, except for the P1 position of the FCV.
Notably, when the entropy scores were calculated on the basis
of amino acid size, they were nearly zero at P1 positions for SaV,
No V, RHDV, and FCV (Fig. 5C; P1). This indicates that changes in
amino acid size are highly restricted at P1 positions independent of
viral genera. In contrast, the entropy scores are around 1.0 at the
P2, P3, and P4 positions for SaV, NoV, RHDV, and FCV (Fig. 5C; P2,
P3, and P4). These data indicate that calicivirus P2, P3, and P4 sites
allow greater variations in amino acid size than the P1 site.
Discussion
Previous mutagenesis studies have reported important roles of
amino acids immediately upstream of the calicivirus cleavage sites
using different cleavage sites, different virus strains, and different
assessment systems of cleavage from ours (Belliot et al., 2003; Robel
et al., 2008; Schefﬂer et al., 2007; Sosnovtsev et al., 1998; Wirblich
et al., 1995) (Supplemental Table 1). The present study extends
their ﬁndings and provides new information regarding structural
and biological constraints on calicivirus substrate diversity.
Present and previous mutagenesis studies have shown that
amino acid substitutions at the P1 site mostly reduced cleavability
of the junction of precursors. These mutations alter the size of side
chains of P1 amino acids (Supplemental Table 1), suggesting a
restriction against size changes in the P1 amino acids. Consistently,
Shannon entropy analysis clearly showed that the P1 site does not
Fig. 5. Amino acid variations at P1, P2, P3, and P4 positions of calicivirus precursor cleavage sites. Shannon entropy scores representing variations at individual amino acid positions (Motomura et al., 2008; Naganawa et al., 2008; Shannon,
1997) were calculated using SaV ORF1, NoV ORF1, RHDV ORF1, and FCV ORF1/ORF2 sequences. A total of 589 cleavage site sequences were used (n=114, 160, 231, and 84 amino acid sequences for SaV, NoV, RHDV, and FCV strains,
respectively). The distribution of entropy scores in each viral genus is shown along with amino acid positions. An entropy score of zero indicates absolute conservation, whereas that of 4.4 indicates complete randomness. Entropy scores based
on amino acids (A), chemical properties of amino acids (B), and size of side chains (C) are indicated.
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126 T. Oka et al. / Virology 394 (2009) 119–129allow variations in amino acid size within the genus of the family
Caliciviridae. Taken together, these ﬁndings strongly suggest
structural constraints on the P1 site that restrict size changes
within each calicivirus genus (Belliot et al., 2003; Blakeney et al.,
2003; Hardy et al., 2002; Liu et al., 1996; Meyers et al., 2000; Oka
et al., 2006; Robel et al., 2008; Seah et al., 1999, 2003; Sosnovtsev
et al., 2006, 2002, 1998; Wirblich et al., 1995).
This conclusion is also conceivable from the point of view of
enzyme structure and reaction. The side chain of the P1 residue is
located near the scissile bonds of the substrate (Nakamura et al.,
2005). Therefore, changes in the size of side chains by mutation will
critically inﬂuence conformation or steric positioning of the scissile
bond in the protease active center. This could result in less efﬁcient
hydrolysis via improper positioning of the scissile bonds, water
molecules, and catalytic residues of protease. Further study is
necessary to clarify this issue. The present mutagenesis study also
demonstrated the functional importance of the P4 site in regulating
substrate cleavability in caliciviruses. Of the 10 cleavage sites
examined, all single mutations at the P4 sites modulated substrate
cleavability either negatively or positively.
The results were consistent with previous reports with SaV
(Robel et al., 2008) and NoV (Hardy et al., 2002) (Supplemental
Table 1). Interestingly, the size of amino acid at the P4 site was
shown to be variable in each of the four genera of the family Cali-
civiridae. These data suggest that the amino acid at the P4 site plays a
role as a key modulator that accommodates size variation and
regulates substrate cleavability either negatively or positively in
caliciviruses.
This conclusion is conceivable from the point of view of enzyme
structure. The catalytic cleft of calicivirus protease can accommodate
several amino acids including the P4 site (Nakamura et al., 2005).
Therefore, the amino acid at the P4 site may interact closely with
some amino acids of the protease catalytic surface. If this were the
case, levels of interactions would critically inﬂuence the conforma-
tion or steric position of the substrate in the protease active center
and thus the substrate cleavability. A study to address this possibility
is now in progress.
While this study strongly suggested the functional importance of
the P1 and P4 sites, that of the P2 and P3 sites remained unclear. An
alanine substitution at the P2 site attenuated substrate cleavability
only in NoV and RHDV. The results are consistent with previous
reports on different cleavage sites of NoV (Belliot et al., 2003) and
RHDV (Wirblich et al., 1995) precursors (Supplemental Table 1). An
alanine substitution at the P3 site also signiﬁcantly attenuated
substrate cleavability only with FCV. Thus far, this is the only example
of positive involvement of a P3 site in the substrate cleavability of a
calicivirus; previous studies have consistently failed to detect
inﬂuences on cleavage by P3 mutations (Robel et al., 2008; Schefﬂer
et al., 2007; Sosnovtsev et al., 2002) (Supplemental Table 1). These
results may imply that the P2 and P3 sites play less crucial roles in
substrate cleavage in calicivirus than the P1 and P4 sites. Alternatively,
the roles they play may be critical but dependent on cleavage sites or
viral genera.
Shannon entropy analysis clearly demonstrated that calicivirus P2
and P3 sites are variable within a genus and accommodate much
greater variations in the size of the amino acid than the P1 site. Taken
together with the mutagenesis results, the variation data suggest that
the P2 and P3 sites may sometimes be involved in the modulation of
substrate cleavability, but less extensively than the P4 site.
Reported full-length sequences of the ORF1 of human SaV (n=19)
show that ﬁve of the six cleavage sites have aromatic amino acids,
such as phenylalanine (F) or tyrosine (Y), at the P4 site (Fig. 1A).
However, the P4 position of the NS4/NS5 cleavage site is exclusively
occupied by a basic rather than aromatic amino acid in all reported
strains (Fig. 1A) (Oka et al., 2006). Notably, we found that a substi-
tution at this P4 site from a basic to an aromatic amino acid convertedthe cleavage site phenotype from low to high sensitivity to sapovirus
protease. These ﬁndings suggest the existence of biological con-
straints on the P4 site to maintain a lower cleavability of the NS4/NS5
site in sapovirus. Such differential cleavability among cleavage sites of
a precursor is reported to be essential for producing mature infectious
viruses in other positively stranded RNA viruses (Gorchakov et al.,
2008; Pathak et al., 2008; Pettit et al., 1994; Wiegers et al., 1998). It
would be interesting to evaluate whether the preservation of lower
levels of cleavability at the NS4/NS5 cleavage site is required for
effective virus replication in the sapovirus.
The functional importance of the P4 and P1 sites for substrate
cleavability has also been reported in other positive-stranded RNA
viruses, such as poliovirus (Blair and Semler, 1991; Pallai et al., 1989)
and hepatitis A virus (Jewell et al., 1992). These viruses belong to the
family Picornaviridae, which is genetically distantly related to the
family Caliciviridae. These results suggest the evolutionary similarity
in mechanisms of substrate recognition and cleavage among these
viral proteases.
In summary, our study has provided some new bases to
understand structural, biological, and evolutionary aspects of the
regulation of precursor processing in caliciviruses. The obtained data
may advance the study of proteolytic processing of positively
stranded RNA virus precursors as well as the development of speciﬁc
inhibitors against caliciviruses.
Materials and methods
Virus strains
The SaV Mc10 strain (GenBank accession no. AY237420) was
isolated from a fecal specimen from an infant hospitalized with acute
gastroenteritis in Thailand in 2000 (Hansman et al., 2004). The NoV
U201 strain (GenBank accession no. AB039782) was isolated from a
fecal specimen from a gastroenteritis outbreak at a hotel in Saitama,
Japan, in 1998 (Kageyama et al., 2004). The RHDV Hokkaido strain
(GenBank accession no. AB300693) was isolated from the liver of a
rabbit with acute hemorrhagic disease in a zoo in Hokkaido, Japan, in
2002. The FCV F4 strain (GenBank accession no. D31836) was
isolated from a cat with respiratory symptoms (Makino et al., 2006;
Takahashi et al., 1971).
Full-length SaV, NoV, and FCV cDNA clones
The full-length cDNA clone containing a native SaV Mc10
genome sequence designated as pUC19/SaV Mc10 full-length, the
full-length cDNA clone containing a mutation in the protease,
pUC19/SaV Mc10 full-C1171A/ORF1, and the six full-length cDNA
clones containing mutation(s) at the cleavage sites of the SaV ORF1
polyprotein—pUC19/SaV Mc10 full-ORF1-E69A, −Q325A, −Q666A,
−E1055A, −E1722A, and −E939A, E940A (E's at amino acid posi-
tions 939 and 940 were changed to A's) have previously described
(Oka et al., 2005, 2006). The plasmid designated as pT7U201F
containing a native full-length NoV Saitama U201 genome with the
T7 promoter has been described previously (Katayama et al., 2006).
The full-length clone containing an FCV F4 genome sequence
designated as pUC19/FCV F4 full-length and a full-length cDNA
clone containing a mutation in the protease, pUC19/FCV F4 full-
C1193A/ORF1, have been described previously (Oka et al., 2007).
Construction of plasmids containing the full-length RHDV genome
Genomic RNA of the RHDV Hokkaido strain was puriﬁed from liver
homogenate from an infected rabbit by the QIAamp Viral RNAMini Kit
(Qiagen KK, Tokyo, Japan). Reverse transcription polymerase chain
reaction (RT-PCR) and complete nucleotide sequence analysis of the
RHDV genome were performed as previously described (Katayama
Table 1
Oligonucleotides used for site-directed mutagenesis in the protease or in the upstream
of the cleavage sites.
Mutant namea Nucleotide sequence (5′–3′)b
SaV Mc10
F66A GCTGCCGCCCCCACAgccACGGAGGAGGGCTTG
T67A GCCGCCCCCACATTCgcgGAGGAGGGCTTGTTAGACTC
E68A GCCGCCCCCACATTCACGgcgGAGGGCTTGTTAGACTC
F322A CTTGTTAAGAGCACGgccCAGTCACAAGGCCCAAC
F663A CTTGATGGAAACCAAGgccAAGGAGCAGGGCAATGAAC
R937A GCCACCCGGTCTGGTgcgGAGGAGGAGGCCAAAGG
R937F GCCACCCGGTCTGGTtttGAGGAGGAGGCCAAAGGAAAG
Y1052A CCCGTAATCAAGGTgccGATGAAGAAGCTCCCACACC
Y1052F CCCGTAATCAAGGTtttGATGAAGAAGCTCCCACACC
F1719A ACCACCAAATTAGTGgccGAAATGGAGGGCCTAGGC
NoV U201
C1150A ACAACACCAGGTGACgccGGGTGCCCCTACGTGTACAAG
Y330A GCCCCCTTACTCGGTGACgccGAGATGCAGGGCCCAGAAG
E331A GCCCCCTTACTCGGTGACTACgcgATGCAGGGCCCAGAAG
M332A GCCCCCTTACTCGGTGACTACGAGgcgCAGGGCCCAGAAGAC
Q333A GGTGACTACGAGATGgcgGGCCCAGAAGACCTG
F696A CACGAGAGAATGGATGAGgccGAGCTCCAAGGCCCTAATCTAC
E697A CGAGAGAATGGATGAGTTCgcgCTCCAAGGCCCTAATCTACC
L698A GAGAATGGATGAGTTCGAGgccCAAGGCCCTAATCTACCAACC
Q699A GAGAATGGATGAGTTCGAGCTCgcaGGCCCTAATCTACCAACC
RHDV Hokkaido
C1212A CAGACCACCCACGGGGACgcgGGGCTACCATTGTATG
A715K AGTGAGCATCCTGATGTGaagTCGTTCGAAGGCGCTAAC
A715W AGTGAGCATCCTGATGTGtggTCGTTCGAAGGCGCTAAC
A715E AGTGAGCATCCTGATGTGgaaTCGTTCGAAGGCGCTAAC
S716A ATCCTGATGTGGCCgcgTTCGAAGGCGCTAACAAATTC
F717A ATCCTGATGTGGCCTCGgccGAAGGCGCTAACAAATTC
E718A CCTGATGTGGCCTCGTTCgcaGGCGCTAACAAATTCAAC
FCV F4
F121A CCAAACCTACCGCTCgccCGATTGGAGGCCGATG
R122A CAAACCTACCGCTCTTCgcaTTGGAGGCCGATGATG
L123A CCTACCGCTCTTCCGAgcgGAGGCCGATGATGGATC
E124A CCGCTCTTCCGATTGgcgGCCGATGATGGATCC
a The name of the mutant represents the amino acid change. Amino acid is shown in
the one-letter code. The letter before the number indicates the original amino acid
residue, and the letter after the number indicates the mutant.
b Only the positive-sense oligonucleotide sequence is shown. The codon
corresponding to changed amino acid is shown in lower case.
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constructed as follows: The 5′ fragment corresponding to nt 1-4832
was ampliﬁed with a sense primer (5′-CAGGGGCCCGGTACCCTGGTA-
ATACGACTCACTATAGTGAAAGTTATGGCGGTTATGTCG-3′), which in-
cluded a KpnI site (underlined), a T7 RNA polymerase promoter
sequence (bold), and an antisense primer (5′-CATCGGAGTCATGGCA-
TAC-3′). The 3′ fragment corresponding to nt 3701-7413 was ampli-
ﬁed with a sense primer (5′-GCTAGGGTTCTCAAAGATG-3′) and an
antisense primer (5′-GAGGTGGAGATGCC ATGCCGACCCt30 ATAGCT-
TACTTTAAAC-3′). HDV ribozyme and T7 terminator sequences were
ampliﬁed from the pT7HCV09Luc plasmid (Yap et al., 1998) with a
sense primer (5′-GGGTCGGCATGGCATCTCCACCTC-3′) and an anti-
sense primer (5′-GAACTAGTGCGGCCGCGAGCTCAGATCTCCTTTCAG-
CAAAAAACCCCTCAAG-3′), which included a NotI site (underlined).
These three DNA fragments were puriﬁed from gel using the QIAquick
Gel Extraction Kit (Qiagen). HDV ribozyme and T7 terminator
sequences were joined with the 3′ fragment corresponding to nt
3701-7413 of the RHDV genome by primerless PCR as previously
described (Katayama et al., 2006; Oka et al., 2007).
The ampliﬁed DNA fragment, designated as RHDV Hokkaido 3701-
7413 polyA-Rz-T7 term, was puriﬁed and digested withMluI (unique
site in the RHDV genome sequence) and NotI. To clone the RHDV
genome sequence, XhoI, MluI, BglII, and NotI sites were added
between the KpnI and BamHI sites in the pUC19 vector (Toyobo,
Osaka, Japan). Then, the insert (RHDVHokkaido 3701-7413 polyA-Rz-
T7 term) was cloned into a modiﬁed pUC19 vector, which had been
previously digested with MluI and NotI. The resultant plasmid was
designated as RHDV Hokkaido 3′-polyA-Rz-T7 term/pUC19. Finally,
the RHDV Hokkaido 5′ region corresponding to nt 1-4832 was
digested with KpnI and MluI (New England Biolabs) and then cloned
into KpnI- and MluI-digested RHDV Hokkaido 3′-polyA-Rz-T7 term/
pUC19. The resultant plasmid containing a full-length RHDVHokkaido
genome sequence with the T7 promoter at the 5′ end, and the poly(A)
tract, ribozyme, and T7 terminator at the 3′ end was designated as
RHDV Hokkaido T7-GG full-length Rz-T7 term/pUC19 ver3 (pUC19/
RHDV Hokkaido full-length). For plasmid cloning, Escherichia coli
DH5α was used. The complete nucleotide sequence of the insert was
determined to conﬁrm the original sequence of the RHDV Hokkaido
strain (GenBank accession number AB300693).
Site-directed mutagenesis
Site-directed mutagenesis was performed using the GeneTailor
Site-Directed Mutagenesis System (Invitrogen), with pUC19/SaV
Mc10 full-length (Oka et al., 2005), pT7U201F (Katayama et al.,
2006), pUC19/RHDV Hokkaido full-length, and pUC19/FCV F4 full-
length (Oka et al., 2007) as the templates. The site-directed
mutagenesis primers in the protease-coding region and in the
upstream of cleavage sites are listed in Table 1.
Ten SaV Mc10 full-length mutant cDNA clones containing a muta-
tion in the upstream of cleavage sites – pUC19/SaVMc10 full−F66A/
ORF1, −T67A/ORF1, −E68A/ORF1, −F322A/ORF1, −F663A/ORF1,
−R937A/ORF1, −R937F/ORF1, −Y1052A/ORF1, −Y1052F/ORF1,
and −F1719A/ORF1 – were constructed. Nine NoV U201 full-length
mutant cDNA clones containing a mutation in the protease or up-
stream of the cleavage sites – pT7 U201 full C1150A /ORF1, Y330A/
ORF1, −E331A/ORF1, −M332A/ORF1, −Q333A/ORF1, −F696A/
ORF1, −E697A/ORF1, −L698A/ORF1, and −Q699A/ORF1 – were
constructed. Seven RHDV Hokkaido full-length mutant cDNA clones
containing amutation in the protease or upstreamof the cleavage site –
pUC19/RHDV Hokkaido full –C1212A/ORF1, −A715K/ORF1,
−A715W/ORF1, −A715E/ORF1, −S716A/ORF1, −F717A/ORF1,
and −E718A/ORF1 – were constructed. Four FCV F4 full-length
mutant cDNA clones containing a mutation upstream of the cleavage
site – pUC19/FCV F4 full −F121A/ORF2, −R122A/ORF2, −L123A/
ORF2, and −E124A/ORF2 – were constructed. Clones were screenedby sequence analysis, and plasmids containing the desired mutations
in the protease or upstream of the cleavage sites were used to
complete the genome sequence analysis. All of these full-length clones
were veriﬁed by sequencing analysis to conﬁrm the absence of
additional mutations leading to amino acid changes.
In vitro-coupled transcription–translation assay
In vitro T7 polymerase-coupled transcription–translation in rabbit
reticulocytes was performed using the TNT T7 Quick for PCR DNA kit
(Promega, Madison, WI). The primers used to generate linear DNA
fragments containing the T7 promoter are shown in Table 2. PCR was
performed with 100 ng of full-length native or mutant cDNA clones as
previously described (Oka et al., 2005, 2006, 2007). To express radio-
labeled polyproteins, 3 μl of the PCR mixture was mixed with 20 μl of
TNT T7 PCR Quick Master Mix (Promega) and 2 μl of Redivue Pro-mix
L-[35S] in vitro cell-labeling mix (GE Healthcare Biosciences), and the
mixture was incubated at 30 °C for 3 or 16 h. The rate of cleavage for
some mutants might be slower than the wild type but still go to
completion in the 3 h incubations. After incubation, 4 μl of the reaction
mixture was mixed with 20 μl of SDS–PAGE sample buffer (62.5 mM
Tris–HCl (pH 6.8), 5% (w/v) sucrose, 2% (w/v) SDS, and 0.002% (w/v)
bromophenol blue with 5% (v/v) 2-mercaptoethanol) and heated at
95 °C for 5 min; then 10 μl of the mixture was loaded onto 5% to 20%
Tris–Gly polyacrylamide gel (D.R.C., Tokyo).
To express the non-radiolabeled polyproteins, 5 μl of the PCR
mixture was mixed with 40 μl of TNT T7 PCR Quick Master Mix
Table 2
PCR primers to prepare templates for in vitro transcription–translation.
Fragmenta Sequence (5′-3′) Nucleotide
positions
Amino acid
positions
SaV entire
ORF1
GCTTCCAAGCCATTCTACCCAATAGAGb 17-6847 1-2278
TTCTAAGAACCTAACGGCCCGGc
NoV entire
ORF1
AAGATGGCGTCTAACGACGCTTCCGTTGb 8-5110 1-1702
TTCGACGCCATCTTCATTCACAAAACTGc
RHDV entire
ORF1
GCGGTTATGTCGCGCb 13-7041 1-2344
GACATAAGAAAAGCCATTAGTTGCc
FCV entire
ORF1
TCTCAAACTCTGAGCTTCGTGb 23-5311 1-1763
TCAAACTTCGAACACATCACAGTGc
FCV capsid
precursor
TGCTCAACCTGCGCTAACGTGb 5317-7317 1-668
TAATTTAGTCATTCTGCTCCTAATGc
a The AUG codon was derived from the original sequence.
b Upper line indicates forward primer, which includes 5′-GGATCCTAATACGACTCAC-
TATAGGGAACAGCCACATG containing the T7 promoter (underlined) and an additional
start codon (bold) at the 5′ end.
c Lower line indicates reverse primer, which includes 5′-T30TTA-3′, corresponding to
polyA with a stop codon (bold) at the 5′ end.
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free water, and the resultant mixture was incubated at 30 °C for 3 h.
Trans cleavage of FCV capsid precursor protein
To examine the cleavage activity of FCV 3C-like protease in trans,
20 μl of in vitro translation reaction mixture containing the non-
radiolabeled protease active or inactive FCV F4 ORF1 polyprotein, a
source of the FCV protease, was mixed with 20 μl of in vitro
translation reaction mixture containing the radiolabeled FCV capsid
precursor (native or mutant), and the resultant 40 μl of the mixture
in total was incubated at 30 °C for 3 h. Then 8 μl of the reaction
mixture was mixed with 20 μl of the SDS–PAGE sample buffer and
heated at 95 °C for 5 min, and then 10 μl of the sample was loaded
onto 5% to 20% Tris–Gly polyacrylamide gel (D.R.C., Tokyo).
Immunoprecipitation
For the radioimmunoprecipitation assay, 10 μl of the reaction
mixture was diluted with 80 μl of RIPA lysis buffer containing 50 mM
Tris, pH 7.4, 150 mM NaCl, 0.25% deoxycholic acid, 1% NP40, 1 mM
EDTA (Upstate, Lake Placid, NY) and incubated with 5 μg of region-
speciﬁc antibodies, anti-A or anti-D raised against E. coli-expressed
recombinant proteins A (aa 1–231) or D (aa 941–1055) (Oka et al.,
2005). After incubation for 1 h on ice, 25 μl of a suspension of protein
A magnetic beads (New England Biolabs) and 900 μl of RIPA buffer
were added. The mixture was gently rotated at 4 °C for 1 h and then
washed three times with 1 ml of RIPA lysis buffer. The immunopre-
cipitated proteins were resuspended in 20 μl of SDS–PAGE sample
buffer and heated at 95 °C for 5 min prior to analysis with 5% to 20%
Tris–Gly polyacrylamide gel.
Analysis of the translated proteins
The translation products were separated by SDS–PAGE. The
proteins in the gel were blotted onto a PVDF membrane (Immobi-
lon-P: Millipore, Bedford, MA) using a semi-dry electroblotting
apparatus (ATTO, Tokyo). The radiolabeled proteins were detected
by a Bioimage Analyzer BAS 2500 (Fuji Film, Tokyo). A panel of
individual mature and intermediate proteins was expressed with the
same system and used for identiﬁcation of the cleavage products
generated from the polyprotein.
Nucleotide and amino acid sequence analyses
To conﬁrm the sequences of the panel of plasmids used in this
study, nucleotide sequence analysis was performed with the Big DyeTerminator (version 3.1) Cycle Sequencing Ready Reaction Kit
(Applied Biosystems, Tokyo, Japan) and an automated sequencer,
the 3130 Genetic Analyzer, or an ABI 3730 xl DNA analyzer (Applied
Biosystems). Nucleotide sequences were assembled with the program
Sequencher™, version 4.7 (Gene Codes Corp., Ann Arbor, MI).
Nucleotide and amino acid sequences were analyzed with GENETYX®
Mac software, version 12.2.6 (Genetyx Corp., Tokyo, Japan).
Analysis of amino acid variation
A total of 98 sequences of calicivirus full-length ORF1 were
collected from a public database (for accession numbers, see Amino
acid sequences section). Cleavage site sequences of ORF1s and VP1
precursor proteins of viruses representing each of the four genera of
the family Caliciviridae (n=114, 160, 231, and 84 sequences for SaV,
NoV, RHDV, and FCV strains, respectively) were aligned with
CLUSTALW Version 1.83 (Thompson et al., 1994).
Amino acid variations at the P1, P2, P3, and P4 positions of the
calicivirus precursor cleavage site were calculated as previously
described (Motomura et al., 2008; Naganawa et al., 2008) on the basis
of Shannon's equation (Shannon, 1997):
H ið Þ = −
X
xi
p xið Þlog2 p xið Þ xi = G; A; I; V ; N Nð Þ;
where H(i), p(xi), and i indicate the amino acid entropy score of a
given position, the probability of occurrence of a given amino acid at
the position, and the number of positions, respectively. An H(i) score
of zero indicates absolute conservation, whereas a score of 4.4
indicates complete randomness.
We also calculated the Shannon entropy by considering the
physicochemical properties of amino acids, i.e., size and chemical
properties. In case of size-based variation analysis, amino acids
are classiﬁed into four groups: small (Gly, Ala, Cys, Ser), medium–
small (Thr, Val, Asn, Asp, Ile, Leu, Pro, Met), medium–large (Gln,
Glu, Arg, Lys), and large (His, Phe, Tyr, Try).
In case of chemical-property-based variation analysis, amino
acids are classiﬁed into seven groups: acidic (Asp, Glu), basic (Arg,
Lys, His), neutral hydrophilic (Ser, Thr, Asn, Gln), aliphatic (Gly, Ala,
Val, Ile, Leu, Met), aromatic (Phe, Tyr, Trp), thio-containing (Cys),
and imine (Pro). The entropy scores were calculated on the assump-
tion that the amino acids within the same group are the same amino
acid.
Amino acid sequences
The following are the accession numbers for the nucleotide
sequences used in the present studies: human SaV strains (n=19),
AY237420, AY237422, X86560, AY694184, AY237423, AY646853,
AY646854, DQ366345, AJ786349, AJ249939, AY603425, AY237419,
AY646855, DQ058829, DQ125333, DQ125334, DQ366346, AY646856,
and DQ366344; human NoV strains (n=32), AB039782, M87661,
AB042808, U07611, X86557, L07418, AF145896, AY032605,
AB039774, AB039775, AB039776, AB039777, AB039778, AB039779,
AB039780, AB039781, AB044366, AB045603, AB081723, AB083780,
AB084071, AB187514, AB365435, AF093797, AY134748, AY237415,
AY587989, AY741811, DQ093067, DQ366347, DQ456824, and
EU310927; RHDV strains (n=33), AB300693, AF258618, AY523410,
DQ189077, DQ205345, DQ280493, EF363035, NC_001543, U54983,
X87607, Z29514, Z49271, EU003578, EU003579, EU003581,
EU003582, AF295785, DQ189078, EF558572, EF558573, EF558574,
EF558575, EF558576, EF558577, EF558578, EF558579, EF558580,
EF558581, EF558582, EF558583, EF558584, EF558585, and
EF558586; and FCV strains (n=14), D31836, AF109465, AF479590,
L40021, M86379, U13992, DQ424892, AY560113, AY560114,
AY560115, AY560116, AY560117, AY560118, and NC_001481.
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